Panic control treatment and its applications
- PMID: 9888103
- PMCID: PMC3330525
Panic control treatment and its applications
Abstract
Panic Control Treatment (PCT) is a widely used, empirically validated cognitive-behavioral treatment for panic disorder. Initially developed for the treatment of panic disorder with limited agoraphobic avoidance, PCT more recently has been finding broader applications. It has been used as an aid to pharmacotherapy discontinuation in panic disorder; in the treatment of panic attacks associated with other disorders such as schizophrenia; and, in combination with a situational exposure component, in the treatment of patients with moderate to severe agoraphobia. The authors critically review the evidence for the clinical efficacy of PCT and recent work directed at further enhancing the long-term efficacy and cost-effectiveness of treatment.
Similar articles
-
Avoidance Moderates Cognitive Behavioral Therapy for Panic Disorder and Agoraphobia.J Nerv Ment Dis. 2020 Oct;208(10):785-793. doi: 10.1097/NMD.0000000000001195. J Nerv Ment Dis. 2020. PMID: 32544125 Clinical Trial.
-
Recognition and treatment of panic disorder.J Clin Psychiatry. 2007 Nov;68(11):e26. doi: 10.4088/jcp.1107e26. J Clin Psychiatry. 2007. PMID: 18052552
-
A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments.J Nerv Ment Dis. 1997 Aug;185(8):510-6. doi: 10.1097/00005053-199708000-00006. J Nerv Ment Dis. 1997. PMID: 9284865
-
[Cognitive-behavioral therapy in panic disorder].Braz J Psychiatry. 2008 Oct;30 Suppl 2:s81-7. doi: 10.1590/s1516-44462008000600005. Braz J Psychiatry. 2008. PMID: 19039448 Review. Portuguese.
-
Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder.J Clin Psychopharmacol. 1998 Dec;18(6 Suppl 2):2S-5S. doi: 10.1097/00004714-199812001-00002. J Clin Psychopharmacol. 1998. PMID: 9872706 Review.
Cited by
-
Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.BMC Pharmacol Toxicol. 2015 Jul 4;16:19. doi: 10.1186/s40360-015-0019-8. BMC Pharmacol Toxicol. 2015. PMID: 26141716 Free PMC article.
References
-
- Hofmann SG, Barlow DH: The costs of anxiety disorders: implications for psychosocial interventions, in Cost-Effectiveness of Psychotherapy, edited by Miller NE, Magruder KM. Oxford, England, Oxford University Press (in press)
-
- Gould RA, Otto MW, Pollack MH: A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995; 15:810–844
-
- Otto MW, Pollack MH, Penava S, et al: The costs and benefits of cognitive-behavioral and pharmacologic treatments for panic disorder. Paper presented to the European Association for Behavioural and Cognitive Therapies, Venice, Italy, September 1997
-
- American Psychiatric Association: Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry 1998; 155(5, suppl) - PubMed
-
- Breier A, Charney DS, Heninger GR: Agoraphobia with panic attacks: development, diagnostic stability, and course of illness. Arch Gen Psychiatry 1986; 43:1029–1036 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical